An early trial of a vaccine made using the technology found it is safe and well-tolerated, with a larger study to include more than 200 people.
Več na: https://www.standard.co.uk/news/science/southampton-cambridge-university-of-cambridge-ebola-virus-sars-b1284918.html
nazaj
